Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019 - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Eurosurveillance Année : 2019

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019

Résumé

Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32-43% against influenza A; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34-38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.

Dates et versions

hal-02355359 , version 1 (08-11-2019)

Identifiants

Citer

Esther Kissling, Angela Rose, Hanne-Dorthe Emborg, Alin Gherasim, Richard Pebody, et al.. Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019. Eurosurveillance, 2019, 24 (8), pp.21. ⟨10.2807/1560-7917.ES.2019.24.1900121⟩. ⟨hal-02355359⟩
47 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More